BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32534476)

  • 1. Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy.
    Bertol BC; de Araújo JNG; Sadissou IA; Sonon P; Dias FC; Bortolin RH; de Figueiredo-Feitosa NL; de Freitas LCC; de Miranda Henrique Tarrapp SR; de Oliveira Ramos CC; Luchessi AD; de Freitas JCOC; Maciel LMZ; Silbiger VN; Donadi EA
    Int J Clin Pract; 2020 Oct; 74(10):e13585. PubMed ID: 32534476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
    Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
    Lv T; Zhu C; Di Z
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
    Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
    Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
    Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
    Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
    Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
    Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
    Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
    Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma.
    Lu H; Zhang L; Dai Y; Ruan Y; Cao X; Cai X; Ruan S; Chen Q
    Diagn Pathol; 2020 Feb; 15(1):16. PubMed ID: 32050977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes of soluble HLA-G and cytokine plasma levels in cervical cancer patients: potential role in cancer progression and immunotherapy.
    Xu HH; Xie YY; Jun-Gan ; Yang Z; Han QY
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4195-4204. PubMed ID: 36053326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
    Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
    J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
    [No Abstract]   [Full Text] [Related]  

  • 15. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
    Lee I; Kim HK; Soh EY; Lee J
    World J Surg; 2020 May; 44(5):1506-1513. PubMed ID: 31915977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
    Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
    Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment for dominant malignant nodules of the isthmus of the thyroid gland: A case control study.
    Karatzas T; Charitoudis G; Vasileiadis D; Kapetanakis S; Vasileiadis I
    Int J Surg; 2015 Jun; 18():64-8. PubMed ID: 25900600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma.
    Shin CH; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY
    Am J Surg; 2020 Oct; 220(4):925-931. PubMed ID: 32081409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.